Abstract
This chapter will survey our current knowledge on lymph formation from the extracellular fluid, lymphatic circulation, and overall lymph proteomic composition during physiological and pathological states. Generation of the lymphatic fluid depends on hydrostatic and osmotic pressure gradients operating in the capillary beds. Lymph movement toward the draining node hinges on the pumping activity of the lymphangions and the presence of unidirectional valves. The lymph proteomic composition is generated by a combination of ultrafiltrated plasma proteins with proteins and molecules generated from the metabolic and catabolic activities of each drained anatomical site. Importantly, lymph proteins and peptides contribute to the MHCII-presented peptidome displayed by nodal dendritic cells. Altogether, these analyses have brought new attention to the role of the lymphatic fluid in transporting the «immunological self» and have indicated how physiological and pathological conditions affect lymph composition.
Highlighted References
Levick JR, Michel CC. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res. 2010;87(19):210.
Clement C, Aphkhazava D, Nieves E, Callaway M, Olszewski W, Rotzschke O, et al. Protein expression profiles of human lymph and plasma mapped by 2D-DIGE and 1D SDS-PAGE coupled with nanoLC-ESI-MS/MS bottom- up proteomics. J Proteomics. 2013;78:172–87.
D’Alessandro A, Dzieciatkowska M, Peltz ED, Moore EE, Jordan JR, Silliman CC, et al. Dynamic changes in rat mesenteric lymph proteins following trauma using label-free mass spectrometry. Shock. 2014;42:509–17.
Tammela T, Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell. 2010;140:460–76.
Clement C, Cannizzo C, Nastke ES, Sahu M-D, Olszewski R, Miller W, et al. An expanded self-antigen peptidome is carried by the human lymph as compared to the plasma. PLoS One. 2010;5:e9863.
References
Santambrogio L. Immunology of the lymphatic system. 1st ed. New York: Springer; 2013.
Starling EH. On the absorption of fluids from the connective tissue spaces. J Physiol. 1896;19:312–26.
Michel CS. The formulation of his hypothesis of microvascular fluid exchange and its significance after 100 years. Exp Physiol. 1997;82:1–30.
Levick. Capillary filtration-absorption balance reconsidered in light of dynamic extravascular factors. Exp Physiol. 1991;76:825–57.
Squire J, Chew M, Nneji M, Neal G, Barry C, Michel J, et al. Quasi-periodic substructure in the microvessel endothelial glycocalyx: a possible explanation for molecular filtering? J Struct Biol. 2001;136:239–55.
Arkill KP, Knupp C, Michel CC, Neal CR, Qvortrup K, Rostgaard J, et al. Similar endothelial glycocalyx structures in microvessels from a range of mammalian tissues: evidence for a common filtering mechanism? Biophys J. 2011;101:1046–56.
Hu X, Adamson RH, Liu B, Curry FE, Weinbaum S. Starling forces that oppose filtration after tissue oncotic pressure is increased. Am J Physiol Heart Circ Physiol. 2000;279:H1724–36.
Adamson RH, Lenz JF, Zhang X, Adamson GN, Weinbaum S, Curry FE. Oncotic pressures opposing filtration across non-fenestrated rat microvessels. J Physiol. 2004;557:889–907.
Veenstra TD, Conrads TP, Hood BL, Avellino AM, Ellenbogen RG, Morrison RS. Biomarkers: mining the biofluid proteome. Mol Cell Proteomics. 2005;4:409–18.
Dzieciatkowska M, D’Alessandro A, Moore EE, Wohlauer M, Banerjee A, Silliman CC, et al. Lymph is not a plasma ultrafiltrate: a proteomic analysis of injured patients. Shock. 2014;42(6):485–98.
Dzieciatkowska M, Wohlauer MV, Moore EE, Damle S, Peltz E, Campsen J, et al. Proteomic analysis of human mesenteric lymph. Shock. 2011;35:331–8.
Fang J-F, Shih L-Y, Yuan K-C, Fang K-Y, Hwang T-L, Hsieh S-Y. Proteomic analysis of post-hemorrhagic shock mesenteric lymph. Shock. 2010;34:291–8.
Mittal A, Middleditch M, Ruggiero K, Buchanan CM, Jullig M, Loveday B, et al. The proteome of rodent mesenteric lymph. Am J Physiol Gastrointest Liver Physiol. 2008;295:G895–903.
Zurawel A, Moore EE, Peltz ED, Jordan JR, Damle S, Dzieciatkowska M, et al. Proteomic profiling of the mesenteric lymph after hemorrhagic shock: differential gel electrophoresis and mass spectrometry analysis. Clin Proteomics. 2010;8:1.
Goldfinch GM, Smith WD, Imrie L, McLean K, Inglis NF, Pemberton AD. The proteome of gastric lymph in normal and nematode infected sheep. Proteomics. 2008;8:1909–18.
Nguyen VPKH, Hanna G, Rodrigues N, Pizzuto K, Yang E, Van Slyke P, et al. Differential proteomic analysis of lymphatic, venous, and arterial endothelial cells extracted from bovine mesenteric vessels. Proteomics. 2010;10:1658–72.
Meens MJ, Sabine A, Petrova TV, Kwak BR. Connexins in lymphatic vessel physiology and disease. FEBS Lett. 2014;588:1271–7.
Baluk P, Fuxe J, Hashizume H, Romano T, Lashnits E, Butz S, et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med. 2007;204:2349–62.
Pflicke H, Sixt M. Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels. J Exp Med. 2009;206:2925–35.
Thomas SN, Rutkowski JM, Pasquier M, Kuan EL, Alitalo K, Randolph GJ, et al. Impaired humoral immunity and tolerance in K14-VEGFR-3-Ig mice that lack dermal lymphatic drainage. J Immunol. 2012;1950(189):2181–90.
Platt AM, Rutkowski JM, Martel C, Kuan EL, Ivanov S, Swartz MA, et al. Normal dendritic cell mobilization to lymph nodes under conditions of severe lymphatic hypoplasia. J Immunol. 2013;1950(190):4608–20.
Gashev AA. Lymphatic vessels: pressure- and flow-dependent regulatory reactions. Ann N Y Acad Sci. 2008;1131:100–9.
Gashev AA, Zawieja DC. Hydrodynamic regulation of lymphatic transport and the impact of aging. Pathophysiol Off J Int Soc Pathophysiol ISP. 2010;17:277–87.
Vittet D. Lymphatic collecting vessel maturation and valve morphogenesis. Microvasc Res. 2014;96:31–7.
Schmid-Schönbein GW. Microlymphatics and lymph flow. Physiol Rev. 1990;70:987–1028.
Muthuchamy M, Zawieja D. Molecular regulation of lymphatic contractility. Ann N Y Acad Sci. 2008;1131:89–99.
Smith JB, McIntosh GH, Morris B. The traffic of cells through tissues: a study of peripheral lymph in sheep. J Anat. 1970;107:87–100.
Swartz MA, Randolph GJ. Introduction to the special issue on lymphangiogenesis in inflammation. Angiogenesis. 2014;17:323–4.
Rahbar E, Akl T, Coté GL, Moore JE, Zawieja DC. Lymph transport in rat mesenteric lymphatics experiencing Edemagenic stress. Microcirculation. 2014;21:359–67.
Cromer WE, Zawieja SD, Tharakan B, Childs EW, Newell MK, Zawieja DC. The effects of inflammatory cytokines on lymphatic endothelial barrier function. Angiogenesis. 2014;17:395–406.
Shields JD. Lymphatics: at the interface of immunity, tolerance, and tumor metastasis. Microcirc. 2011;1994(18):517–31.
Gertler F, Condeelis J. Metastasis: tumor cells becoming MENAcing. Trends Cell Biol. 2011;21:81–90.
Shin K, Kataru RP, Park HJ, Kwon B-I, Kim TW, Hong YK, et al. TH2 cells and their cytokines regulate formation and function of lymphatic vessels. Nat Commun. 2015;6:6196.
Angeli V, Ginhoux F, Llodrà J, Quemeneur L, Frenette PS, Skobe M, et al. Cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity. 2006;24:203–15.
Marchiò S, Astanina E, Bussolino F. Emerging lymphae for the fountain of life. EMBO J. 2013;32:609–11.
Hägerling R, Pollmann C, Andreas M, Schmidt C, Nurmi H, Adams RH, et al. A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy. EMBO J. 2013;32:629–44.
Srinivasan RS, Escobedo N, Yang Y, Interiano A, Dillard ME, Finkelstein D, et al. The Prox1-Vegfr3 feedback loop maintains the identity and the number of lymphatic endothelial cell progenitors. Genes Dev. 2014;28:2175–87.
Zheng W, Aspelund A, Alitalo K. Lymphangiogenic factors, mechanisms, and applications. J Clin Invest. 2014;124:878–87.
Flister MJ, Wilber A, Hall KL, Iwata C, Miyazono K, Nisato RE, et al. Inflammation induces lymphangiogenesis through up- regulation of VEGFR-3 mediated by NF-kappaB and Prox1. Blood. 2010;115:418–29.
Srinivasan RS, Geng X, Yang Y, Wang Y, Mukatira S, Studer M, et al. The nuclear hormone receptor coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. Genes Dev. 2010;24:696–707.
Leak LV, Liotta LA, Krutzsch H, Jones M, Fusaro VA, Ross SJ, et al. Proteomic analysis of lymph. Proteomics. 2004;4:753–65.
Mittal A, Phillips ARJ, Middleditch M, Ruggiero K, Loveday B, Delahunt B, et al. The proteome of mesenteric lymph during acute pancreatitis and implications for treatment. JOP J Pancreas. 2009;10:130–42.
Clement CC, Santambrogio L. The lymph self-antigen repertoire. Front Immunol. 2013;4:424.
Magnotti LJ, Upperman JS, Xu DZ, Lu Q, Deitch EA. Gut-derived mesenteric lymph but not portal blood increases endothelial cell permeability and promotes lung injury after hemorrhagic shock. Ann Surg. 1998;228:518–27.
Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, Hermjakob H, et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics. 2005;5:3226–45.
Omenn GS, Aebersold R, Paik Y-K. 7th HUPO World Congress of Proteomics: launching the second phase of the HUPOPlasma Proteome Project PPP-2 16-20 August 2008, Amsterdam, The Netherlands. Proteomics. 2009;9:4–6.
Clement CC, Rotzschke O, Santambrogio L. The lymph as a pool of self-antigens. Trends Immunol. 2011;32:6–11.
Badylak SF, Freytes DO, Gilbert TW. Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater. 2009;5:1–13.
Korpos E, Wu C, Sorokin L. Multiple roles of the extracellular matrix in inflammation. Curr Pharm Des. 2009;15:1349–57.
Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012;196:395–406.
Shiomi T, Lemaître V, D’Armiento J, Okada Y. Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases. Pathol Int. 2010;60:477–96.
Gaggar A, Jackson PL, Noerager BD, O’Reilly PJ, McQuaid DB, Rowe SM, et al. A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J Immunol. 2008;180:5662–9.
Wohlauer, M. Moore, E. E. Silliman, C. C. Fragoso, M. Gamboni, F. Harr, J. Accurso, F. Wright, F. Haenel, J. 2012. Fullerton, D. et al. Nebulized hypertonic saline attenuates acute lung injury following trauma and hemorrhagic shock via inhibition of matrix metalloproteinase-13. Crit Care Med 40:2647–2653.
Naranjo V, Villar M, Martín-Hernando MP, Vidal D, Höfle U, Gortazar C, et al. Proteomic and transcriptomic analyses of differential stress/inflammatory responses in mandibular lymph nodes and oropharyngeal tonsils of European wild boars naturally infected with Mycobacterium Bovis. Proteomics. 2007;7:220–31.
Popova TG, Espina V, Zhou W, Mueller C, Liotta L, Popov SG. Whole proteome analysis of mouse lymph nodes in cutaneous anthrax. PLoS One. 2014;9:e110873.
Oveland E, Karlsen TV, Haslene-Hox H, Semaeva E, Janaczyk B, Tenstad O, et al. Proteomic evaluation of inflammatory proteins in rat spleen interstitial fluid and lymph during LPS-induced systemic inflammation reveals increased levels of ADAMST1. J Proteome Res. 2012;11:5338–49.
Haenen S, Clynen E, De Vooght V, Schoofs L, Nemery B, Hoet PHM, et al. Proteome changes in auricular lymph nodes and serum after dermal sensitization to toluene diisocyanate in mice. Proteomics. 2012;12:3548–58.
Diebel LN, Liberati DM, Ledgerwood AM, Lucas CE. Changes in lymph proteome induced by hemorrhagic shock: the appearance of damage-associated molecular patterns. J Trauma Acute Care Surg. 2012;73:41–50.
Zhang P, Li Y, Zhang L-D, Wang L-H, Wang X, He C, et al. Proteome changes in mesenteric lymph induced by sepsis. Mol Med Rep. 2014;10:2793–804.
Ling XB, Mellins ED, Sylvester KG, Cohen HJ. Urine peptidomics for clinical biomarker discovery. Adv Clin Chem. 2010;51:181–213.
Sturm T, Leinders-Zufall T, Maček B, Walzer M, Jung S, Pömmerl B, et al. Mouse urinary peptides provide a molecular basis for genotype discrimination by nasal sensory neurons. Nat Commun. 2013;4:1616.
Trindade F, Amado F, Pinto da Costa J, Ferreira R, Maia C, Henriques I, et al. Salivary peptidomic as a tool to disclose new potential antimicrobial peptides. J Proteomics. 2015;115:49–57.
Castagnola M, Cabras T, Vitali A, Sanna MT, Messana I. Biotechnological implications of the salivary proteome. Trends Biotechnol. 2011;29:409–18.
Geho DH, Liotta LA, Petricoin EF, Zhao W, Araujo RP. The amplified peptidome: the new treasure chest of candidate biomarkers. Curr Opin Chem Biol. 2006;10:50–5.
Nygard NR, Giacoletto KS, Bono C, Gorka J, Kompelli S, Schwartz BD. Peptide binding to surface class II molecules is the major pathway of formation of immunogenic class II-peptide complexes for viable antigen presenting cells. J Immunol Baltim Md. 1994;152:1082–93.
Ploegh HL. MHC products: biosynthesis, intracellular traffic, and «empty» molecules. Cold Spring Harb Symp Quant Biol. 1992;57:565–70.
Schumacher TN, Heemels MT, Neefjes JJ, Kast WM, Melief CJ, Ploegh HL. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell. 1990;62:563–7.
De Bruijn ML, Schumacher TN, Nieland JD, Ploegh HL, Kast WM, Melief CJ. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses. Eur J Immunol. 1991;21:2963–70.
Santambrogio L, Sato AK, Carven GJ, Belyanskaya SL, Strominger JL, Stern LJ. Extracellular antigen processing and presentation by immature dendritic cells. Proc Natl Acad Sci. 1999;96:15056–61.
Santambrogio L, Sato AK, Fischer FR, Dorf ME, Stern LJ. Abundant empty class II MHC molecules on the surface of immature dendritic cells. Proc Natl Acad Sci. 1999;96:15050–5.
Shen Y, Liu T, Tolić N, Petritis BO, Zhao R, Moore RJ, et al. Strategy for degradomic-peptidomic analysis of human blood plasma. J Proteome Res. 2010;9:2339–46. doi:10.1021/pr901083m.
Shen Y, Tolić N, Liu T, Zhao R, Petritis BO, Gritsenko MA, et al. Blood peptidome-degradome profile of breast cancer. PLoS One. 2010;5:e13133.
Pang B, Neijssen J, Qiao X, Janssen L, Janssen H, Lippuner C, et al. Direct antigen presentation and gap junction mediated cross-presentation during apoptosis. J Immunol. 2009;1950(183):1083–90.
Goldschneider I, Cone RE. A central role for peripheral dendritic cells in the induction of acquired thymic tolerance. Trends Immunol. 2003;24:77–81.
Bonasio R, Scimone ML, Schaerli P, Grabie N, Lichtman AH, von Andrian UH. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat Immunol. 2006;7:1092–100.
Zal T, Volkmann A, Stockinger B. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J Exp Med. 1994;180:2089–99.
Campbell JD, Buckland KF, McMillan SJ, Kearley J, Oldfield WLG, Stern LJ, et al. Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J Exp Med. 2009;206:1535–47.
Chowdhury NC, Jin MX, Hardy MA, Oluwole SF. Donor-specific unresponsiveness to murine cardiac allografts induced by intrathymic-soluble alloantigens is dependent on alternate pathway of antigen presentation. J Surg Res. 1995;59:91–6. doi:10.1006/jsre.1995.1137.
Gallegos AM, Bevan MJ. Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J Exp Med. 2004;200:1039–49.
Liblau RS, Tisch R, Shokat K, Yang X, Dumont N, Goodnow CC, et al. Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis. Proc Natl Acad Sci. 1996;93:3031–6.
Oluwole SF, Jin MX, Chowdhury NC, Engelstad K, Ohajekwe OA, James T. Induction of peripheral tolerance by intrathymic inoculation of soluble alloantigens: evidence for the role of host antigen-presenting cells and suppressor cell mechanism. Cell Immunol. 1995;162:33–41.
Shimomura K, Hardy MA, Oluwole SF. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens. Transplantation. 1995;60:806–11.
Lovitch SB, Esparza TJ, Schweitzer G, Herzog J, Unanue ER. Activation of type B T cells after protein immunization reveals novel pathways of in vivo presentation of peptides. J Immunol Baltim. 2007;1950(178):122–33.
Strong BSI, Unanue ER. Presentation of type B peptide-MHC complexes from hen egg white lysozyme by TLR ligands and type I IFNs independent of H2-DM regulation. J Immunol. 2011;1950(187):2193–201. doi:10.4049/jimmunol.1100152.
Volkmann A, Zal T, Stockinger B. Antigen-presenting cells in the thymus that can negatively select MHC class II-restricted T cells recognizing a circulating self antigen. J Immunol. 1997;1950(158):693–706.
Donskoy E, Goldschneider I. Two developmentally distinct populations of dendritic cells inhabit the adult mouse thymus: demonstration by differential importation of hematogenous precursors under steady state conditions. J Immunol. 2003;1950(170):3514–21.
Idoyaga J, Fiorese C, Zbytnuik L, Lubkin A, Miller J, Malissen B, et al. Specialized role of migratory dendritic cells in peripheral tolerance induction. J Clin Invest. 2013;123:844–54. doi:10.1172/JCI65260.
Lovitch SB, Walters JJ, Gross ML, Unanue ER. APCs present a beta(k)-derived peptides that are autoantigenic to type B T cells. J Immunol. 2003;1950(170):4155–416.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Santambrogio, L. (2018). Lymph Formation and Composition. In: Lee, BB., Rockson, S., Bergan, J. (eds) Lymphedema. Springer, Cham. https://doi.org/10.1007/978-3-319-52423-8_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-52423-8_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52421-4
Online ISBN: 978-3-319-52423-8
eBook Packages: MedicineMedicine (R0)